Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Osoba

Showing results (101-110 of 123) with videos related to

Pageof 13
Sort By:
International Journal of Radiation Oncology, Biology, Physics|February 1, 1988
The effect of dose of thoracic irradiation on recurrence in patients with limited stage small cell lung cancer. Initial results of a Canadian Multicenter Randomized TrialP Coy, I Hodson, D G Payne, et al.
Journal of the National Cancer Institute|August 21, 1991
Superiority of granisetron to dexamethasone plus prochlorperazine in the prevention of chemotherapy-induced emesisD Warr, A Willan, S Fine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1987
Canadian multicenter randomized trial comparing sequential and alternating administration of two non-cross-resistant chemotherapy combinations in patients with limited small-cell carcinoma of the lungR Feld, W K Evans, P Coy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1991
A randomized, double-blinded study comparing six doses of batanopride (BMY-25801) with methylprednisolone in patients receiving moderately emetogenic chemotherapyJ Rusthoven, J Pater, L Kaizer, et al.
Oncology (Williston Park, N.Y.)|April 1, 1994
Quality of life, appetite, and weight change in patients receiving dose-intensive chemotherapyD Osoba, N Murray, K Gelmon, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|October 1, 1988
Failure of methylprednisolone acetate to prolong the antinauseant effect of intravenous methylprednisolone sodium succinate in patients receiving chemotherapyD Osoba, C Erlichman, A R Willan, et al.
Seminars in Oncology|September 1, 1986
The use of VP-16 plus cisplatin during induction chemotherapy for small-cell lung cancerW K Evans, R Feld, N Murray, et al.
Medical Care|May 1, 1997
The use of significant others as proxy raters of the quality of life of patients with brain cancerK C Sneeuw, N K Aaronson, D Osoba, et al.
The American Journal of Medicine|November 1, 1979
Kaposi's sarcoma in recipients of renal transplantsA R Harwood, D Osoba, S L Hofstader, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1994
Use of palliative end points to evaluate the effects of mitoxantrone and low-dose prednisone in patients with hormonally resistant prostate cancerM J Moore, D Osoba, K Murphy, et al.
Pageof 13

Showing results (101-110 of 123) with videos related to

Sort By:
Pageof 13
International Journal of Radiation Oncology, Biology, Physics|February 1, 1988
The effect of dose of thoracic irradiation on recurrence in patients with limited stage small cell lung cancer. Initial results of a Canadian Multicenter Randomized TrialP Coy, I Hodson, D G Payne, et al.
Journal of the National Cancer Institute|August 21, 1991
Superiority of granisetron to dexamethasone plus prochlorperazine in the prevention of chemotherapy-induced emesisD Warr, A Willan, S Fine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1987
Canadian multicenter randomized trial comparing sequential and alternating administration of two non-cross-resistant chemotherapy combinations in patients with limited small-cell carcinoma of the lungR Feld, W K Evans, P Coy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1991
A randomized, double-blinded study comparing six doses of batanopride (BMY-25801) with methylprednisolone in patients receiving moderately emetogenic chemotherapyJ Rusthoven, J Pater, L Kaizer, et al.
Oncology (Williston Park, N.Y.)|April 1, 1994
Quality of life, appetite, and weight change in patients receiving dose-intensive chemotherapyD Osoba, N Murray, K Gelmon, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|October 1, 1988
Failure of methylprednisolone acetate to prolong the antinauseant effect of intravenous methylprednisolone sodium succinate in patients receiving chemotherapyD Osoba, C Erlichman, A R Willan, et al.
Seminars in Oncology|September 1, 1986
The use of VP-16 plus cisplatin during induction chemotherapy for small-cell lung cancerW K Evans, R Feld, N Murray, et al.
Medical Care|May 1, 1997
The use of significant others as proxy raters of the quality of life of patients with brain cancerK C Sneeuw, N K Aaronson, D Osoba, et al.
The American Journal of Medicine|November 1, 1979
Kaposi's sarcoma in recipients of renal transplantsA R Harwood, D Osoba, S L Hofstader, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1994
Use of palliative end points to evaluate the effects of mitoxantrone and low-dose prednisone in patients with hormonally resistant prostate cancerM J Moore, D Osoba, K Murphy, et al.
Pageof 13